SPINK1 and prostate neoplasm: The expression of Spink1 in prostate tumors has shown promise as an independent predictor of biochemical recurrence after resection; most excitingly, is able to be detected in the urine—making it a less-invasive alternative to sampling previous biomarkers [20].